Angiotensin II (ANG II) plays an important role in the pathogenesis of atherosclerosis by inducing proliferation of vascular smooth muscle cells (VSMCs). In our study, we observed the effects of valsartan on proliferation of cultured VSMCs treated with or without ANG II by cell counting and methyl thiazolyl tetrazolium (MTT) assay, and detected the expression of mitofusin 2 (Mfn2), a newly discovered cell proliferation inhibitor and a related cell proliferation signaling pathway protein by Western blotting. ANG II at a concentration of 10(-6) mol/L significantly stimulated VSMCs proliferation, down-regulated the expression of Mfn2 and up-regulated the expression of Raf and ERK1/2. Valsartan inhibited such effects of ANG II at concentrations of 10(-5) and 10(-6) mol/L, but not at 10(-7) mol/L. Valsartan had no significant effect on the proliferation of untreated VSMCs. These results suggest that valsartan inhibits ANG II-induced proliferation of VSMCs in vitro via Mfn2-Ras-Raf-ERK/MAPK signaling pathway.
基金:
National Natural Science Foundation of China [30872714, 30971244]
第一作者单位:[1]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Cardiol, Wuhan 430030, Peoples R China[2]Cent Hosp Wuhan, Dept Cardiol, Wuhan 430014, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Liao Hua,Gong Junrong,Zhang Wenjuan,et al.Valsartan Inhibits Angiotensin II-induced Proliferation of Vascular Smooth Muscle Cells via Regulating the Expression of Mitofusin 2[J].JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES.2012,32(1):31-35.doi:10.1007/s11596-012-0005-y.
APA:
Liao, Hua,Gong, Junrong,Zhang, Wenjuan&Guo, Xiaomei.(2012).Valsartan Inhibits Angiotensin II-induced Proliferation of Vascular Smooth Muscle Cells via Regulating the Expression of Mitofusin 2.JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES,32,(1)
MLA:
Liao, Hua,et al."Valsartan Inhibits Angiotensin II-induced Proliferation of Vascular Smooth Muscle Cells via Regulating the Expression of Mitofusin 2".JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES 32..1(2012):31-35